Skip to main navigation Skip to search Skip to main content

A phase III Randomized Observer Blind Controlled Multicenter Clinical Study to Evaluate the Efficacy Safety and Immunogenicity of an MF59 Adjuvanted Quandrivalent Influenza Vaccine Comparator in Adults 65 years of Age

  • Ünal, Serhat (CoI)

Project: ResearchOTHER

Project Details

StatusFinished
Effective start/end date1/12/161/12/17